[Retracted] Combined application of Embelin and tumor necrosis factor‑related apoptosis‑inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase‑induced apoptosis
Oncology Letters · 08.06.2026 · 32 (2) · 1-1
DOI: 10.3892/ol.2026.15687 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 08.06.2026. Verfasst von Hao Qian und 8 weiteren Autor:innen. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Qian, H., Chen, Y., Huang, T., Liu, T., Li, X., Jiang, G., Zhang, W., Cheng, S., & Li, P. (2026). [Retracted] Combined application of Embelin and tumor necrosis factor‑related apoptosis‑inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase‑induced apoptosis. Oncology Letters, 32(2), 1-1. https://doi.org/10.3892/ol.2026.15687
Vancouver
Qian H, Chen Y, Huang T, Liu T, Li X, Jiang G, et al. [Retracted] Combined application of Embelin and tumor necrosis factor‑related apoptosis‑inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase‑induced apoptosis. Oncology Letters. 2026;32(2):1-1. doi:10.3892/ol.2026.15687
BibTeX
@article{Qian2026,
author = {Qian, Hao and Chen, Yao and Huang, Tao and Liu, Tiemin and Li, Xiucheng and Jiang, Guangjian and Zhang, Wei and Cheng, Shuo and Li, Pengcheng},
title = {[Retracted] Combined application of Embelin and tumor necrosis factor‑related apoptosis‑inducing ligand inhibits proliferation and invasion in osteosarcoma cells via caspase‑induced apoptosis},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {2},
pages = {1--1},
doi = {10.3892/ol.2026.15687}
}
EUVIMED